|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/7088 | (2006.01) | ||
| A61K 31/712 | (2006.01) | ||
| A61P 27/02 | (2006.01) |
| (11) | Number of the document | 3516060 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17781030.6 |
| Date of filing the European patent application | 2017-09-22 | |
| (97) | Date of publication of the European application | 2019-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/074133 |
| Date | 2017-09-22 |
| (87) | Number | WO 2018/055134 |
| Date | 2018-03-29 |
| (30) | Number | Date | Country code |
| 201616202 | 2016-09-23 | GB |
| (72) |
VAN DIEPEN, Hester Catharina , NL
TURUNEN, Janne Juha , NL
CHAN, Hee Lam , NL
|
| (73) |
ProQR Therapeutics II B.V. ,
Zernikedreef 9, 2333 CK Leiden,
NL
|
| (54) | ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE |
| ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE |